Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application
Vascular pathology is the second most common neuropathology of dementia after Alzheimer’s disease (AD), with small vessels disease (SVD) being considered the major cause of vascular cognitive impairment and dementia (VCID). This review aims to evaluate pathophysiological pathways underlyin...
Main Authors: | Virginia Cipollini, Fernanda Troili, Franco Giubilei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/11/2812 |
Similar Items
-
Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia
by: Feng Zhang, et al.
Published: (2021-09-01) -
Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
by: Annika Öhrfelt, et al.
Published: (2011-01-01) -
Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia
by: Yue Liu, et al.
Published: (2020-01-01) -
Vascular cognitive impairment and vascular dementia
by: Klavdija Ovčar, et al.
Published: (2017-09-01) -
The profile of behavioral and psychological symptoms in vascular cognitive impairment with and without dementia
by: Meena Gupta, et al.
Published: (2013-01-01)